NEW YORK, Sept. 20 (UPI) — Recent advances in chronic obstructive pulmonary disease offer patients more hope in easing discomfort from a condition that can cause severe airflow blockage and breathing-related problems.
The umbrella of diseases, which includes emphysema and bronchitis, is the third-leading cause of global mortality, accounting for more than 3 million deaths in 2019, according to the latest statistics from the World Health Organization.
